Acute heart transplant rejection due to Saint John's wort

Lancet

Volumn 355, Issue 9203, 2000, Pages 548-549

  Ruschitzka, Frank ^a   Meier, Peter J ^a   Turina, Marko ^a   Lüscher, Thomas F ^a   Noll, Georg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; CYTOCHROME P450; HYPERICUM PERFORATUM EXTRACT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG BIOAVAILABILITY; GRAFT REJECTION; HEART GRAFT; HUMAN; HYPERICUM PERFORATUM; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0034639638     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05467-7     Document Type: Article

References (4)

1. Linde K., Ramirez G., Muirow C.D.et al. St John's wort for depression: an overview and metaanalysis of randomized clinical trials. BMJ. 313:1996;253-258.
2. Conney A.H. Induction of microsomal cytochrome P-450 enzymes. Life Sciences. 39:1986;2493-2518.
3. Johne A., Brockmöller J., Bauer S., Maurer A., Langheinrich M., Roots I. Pharmakokinetic interaction of digoxin with an herbal extract from St John's wort (hypericum perforatum). Clin Pharmacol Ther. 66:1999;338-345.
4. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A.A.M., Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmakokinetics of dexamethasone, digoxin, and ciclosporin a. J Clin Invest. 96:1995;1698-1705.